Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-09-30Visual Impairment, Oscillopsia and Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2010-09-13A Phase 2a Magnetic Resonance Imaging Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2010-08-11The Effects of Vitamin D3 Supplementation on the T Cell Compartment in Multiple Sclerosis; a Pilot Study
-
CLINICAL_TRIALS study record update · 2010-08-11International, Multicenter, Single-arm, Open-label, 12-week Phase IIIb Study to Evaluate RebiSmart™ Suitability for Self Injection of Rebif® New Formulation (RNF) in Multidose Cartridges in Patients With Relapsing Form of Multiple Sclerosis (RMS)
-
CLINICAL_TRIALS study record update · 2010-07-13Quantification of Novel Immune Markers in Human Serum of Patients With MS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-07-09A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate the Safety and Antigenicity of Rebif® (Interferon-beta-1a) in Subjects With Relapsing Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2010-07-01Long-term Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Neramexane Mesylate in Congenital Idiopathic Nystagmus and Acquired Nystagmus
-
CLINICAL_TRIALS study record update · 2010-06-28Evaluation of Macular and Retinal Nerve Fiber Layer Thickness Measurements for Detection of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Optical Coherence Tomography.
-
CLINICAL_TRIALS study record update · 2010-06-24The Validation of a New Method to Evaluate the Effects of Chemoneurolytic Intervention on Balance and Community Ambulation in Spastic Hemiplegic Patients
-
CLINICAL_TRIALS study record update · 2010-06-23Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2010-06-02Rebif® Pregnancy Registry
-
CLINICAL_TRIALS study record update · 2010-04-16Study of the Efficacy and Safety of FolateScan (Technetium TC99m EC20) in Patients With Rheumatoid Arthritis and Other Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2010-03-08Avonex® Fifteen Year Long Term Follow Up of Patients With Relapsing Multiple Sclerosis: ASSessment of Drug Utilization, EaRly TreAtmeNt, and Clinical OutcomEs
-
CLINICAL_TRIALS study record update · 2010-03-05Single Center, Pilot Study to Measure ATP Expression in Lymphocytes of MS Patients Undergoing Various Therapies by Means of Using the "ImmuKnow®" Test
-
CLINICAL_TRIALS study record update · 2010-02-10A Multicenter Longitudinal Cross-sectional Pilot Study, to Compare RNFL Thickness Measured by OCT After Treatment With Glatiramer or After no Treatment in Patients With CIS With or Without Optic Neuritis or With Early RRMS
-
CLINICAL_TRIALS study record update · 2010-02-10Open Label Study to Evaluate the Effect, Safety and Tolerability of 250µg (8 MIU) Interferon Beta 1b (Betaferon) Given Subcutaneously Every Other Day (for 24 Weeks) in Patients of Chinese Origin With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2010-01-27Climate Influence on Physiotherapy in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2010-01-27A Multicenter, Prospective and Retrospective, Long-Term Observational Study of AVONEX® and Rebif® to Determine the Efficacy, Tolerability, and Safety in Subjects With Relapsing Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2009-12-18Double-blind, Randomised,Placebo-controlled Trial of Levetiracetam in Central Pain in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-12-07Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-12-02A Phase II, Double-blind, Placebo-Controlled, Randomized, Dose-ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12p40(CNTO1275) in Subjects With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-11-25An Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis: A Multi-Parametric Non-Conventional MRI Sub-Study in Patient Participating in the CARE MS I and CARE MS II Studies
-
CLINICAL_TRIALS study record update · 2009-11-09Double-blind, Randomized, Parallel Group, Multicenter Study of the Safety and Tolerability of Betaseron 500 Mcg Subcutaneously Every Other Day and Betaseron 250 Mcg Subcutaneously Every Other Day for at Least 12 Weeks in Patients With RRMS
-
CLINICAL_TRIALS study record update · 2009-09-29Characteristic Study on Chinese Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-08-13A Multicenter, Open-Label Immunogenicity and Safety Study of Natalizumab High Titer Material (BG00002-E) in Subjects With Relapsing Forms of Multiple Sclerosis